Developing a new method to identify individuals at risk for psychosis
CAPER: Computerized Assessment of Psychosis Risk
This study is testing a new online tool to help identify people who might be at risk for psychosis earlier, so they can get the support they need sooner, and it’s designed for anyone who may be concerned about their mental health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10982602 on NIH RePORTER |
What this research studies
This research focuses on improving the early identification of individuals at clinical high risk for psychosis by developing a new assessment tool called the psychosis symptom domain sensitive (PSDS) battery. The approach involves using behavioral tasks that can be administered online, making it more accessible for individuals seeking help. By recruiting participants with varying levels of psychosis risk, the study aims to determine which tasks effectively predict the course of the illness and how this new method compares to existing prediction techniques. This could lead to better screening and earlier intervention for those at risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are experiencing early symptoms of psychosis or are at clinical high risk for developing psychosis.
Not a fit: Patients who are not experiencing any symptoms of psychosis or are not at risk for developing psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and accessible methods for identifying individuals at risk for psychosis, potentially improving their treatment outcomes.
How similar studies have performed: Other research has shown promise in using machine learning and online assessments for predicting mental health outcomes, indicating that this approach may be effective.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ellman, Lauren M — Temple Univ of the Commonwealth
- Study coordinator: Ellman, Lauren M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.